Skip to main content

UBS Group AG

Position in ADIL — Adial Pharmaceuticals, Inc.

CIK 1610520 ZURICH, V8

Position in ADIL

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$49,015
+$48,045 QoQ
Shares Held
19,147
+3432.7% QoQ
Ownership
0.729%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#4
of 17 holders
Holding Since
Sep 2020
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ADIL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,675,801 across 560 Biotechnology names. ADIL ranks #395 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ADIL

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $49,015 19,147
2026-03-31 $970 542
2025-12-31 $2,015 9,167
2025-09-30 $6,564 18,758
2025-06-30 $3,718 12,395
2025-03-31 $30,079 47,745
2024-12-31 $21,227 21,018
2024-09-30 $4,404 4,404
2024-06-30 $96,145 83,605
2024-03-31 $7,615 5,726
2023-12-31 $6,736 3,622
2023-09-30 $1,517 546
2023-03-31 $3,720 10,630
2022-12-31 $4,852 22,055
2022-09-30 $12,430 35,517
2022-03-31 $13,748 6,840
2021-12-31 $9,784 3,624
2021-09-30 $18,833 4,390
2021-03-31 $10,761 4,447
2020-12-31 $18,902 11,119
2020-09-30 $2,945 1,321